Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer
Crossref DOI link: https://doi.org/10.1186/s13046-023-02593-5
Published Online: 2023-01-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Jiahui
Liu, Deying
Niu, Huilin
Zhu, Guifang
Xu, Yangwei
Ye, Danli
Li, Jian
Zhang, Qingling
Text and Data Mining valid from 2023-01-17
Version of Record valid from 2023-01-17
Article History
First Online: 17 January 2023